3D Medicines, Inc.(HK:1244)
HK$2.50-0.07 (-2.73%)
HK:1244
3D Medicines, Inc. financials statements
HK$2.50
At close:-0.07 (-2.73%)
Want to see HK:1244 full AI Analyst Report?
3D Medicines, Inc. (1244) Income Statement
3 Followers
3D Medicines, Inc. Income Statement
Last quarter (Q2 2026), 3D Medicines, Inc.'s total revenue was ¥210.75M, an increase of 2.10% from the same quarter last year. In Q2, 3D Medicines, Inc.'s net income was ¥-85.32M. See 3D Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 356.09M | ¥ 445.65M | ¥ 634.95M | ¥ 567.39M | ¥ 60.26M | |
| ¥ 298.97M | ¥ 371.74M | ¥ 524.01M | ¥ 525.18M | ¥ 55.98M | |
| ¥ 411.62M | ¥ 495.17M | ¥ 1.02B | ¥ 846.54M | ¥ 559.07M | |
| Depreciation and Amortization | ¥ 15.16M | ¥ 25.25M | ¥ 25.46M | ¥ 21.60M | ¥ 12.59M |
| ¥ -191.18M | ¥ -209.56M | ¥ -529.23M | ¥ -1.03B | ¥ -1.45B | |
| ¥ -112.65M | ¥ -123.43M | ¥ -497.25M | ¥ -386.17M | ¥ -516.25M | |
| ¥ -72.29M | ¥ -75.95M | ¥ -65.22M | ¥ -665.86M | ¥ -945.57M | |
| ¥ -184.94M | ¥ -199.38M | ¥ -562.47M | ¥ -1.05B | ¥ -1.46B | |
| ¥ -177.53M | ¥ -182.66M | ¥ -524.70M | ¥ -1.02B | ¥ -1.43B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.72 | ¥ -0.75 | ¥ -2.30 | ¥ -22.52 | ¥ -36.72 |
| Diluted EPS | ¥ -0.72 | ¥ -0.75 | ¥ -2.30 | ¥ -22.52 | ¥ -36.72 |
| Weighted Average Shares Outstanding | 245.49M | 244.96M | 228.47M | 45.49M | 39.05M |
| Weighted Average Shares Outstanding (Diluted) | 245.49M | 244.96M | 228.47M | 45.49M | 39.05M |
Currency in CNY

